Skip to Main Content
Our Commitment to Diversity

When Regulatory Review is Necessary: Clinical Research vs. Quality Initiatives

Share via LinkedIn
Share via Twitter
Share via Facebook
Date: 15 July 2021
Triage
By: Rebecca M. Schaefer

In this week’s episode, Richard Church interviews Rebecca Schaefer about the intersection and blurred line between clinical research and quality initiatives. The presenters discuss what factors to consider when defining research, the regulatory requirements for research, and HIPAA exemptions to the Common Rule. 

Rebecca M. Schaefer
Rebecca M. Schaefer
Research Triangle Park
Find more items tagged as: Academic Medical Centers (AMCs), Health Care and FDA, Health Care Sector, Policy and Regulatory
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel